Cardiovascular disease is the greatest cause of death worldwide. Atherosclerosis is the
underlying pathology responsible for two thirds of these deaths. It is the age‐dependent …

Objectives The authors sought to compare the differential effects of ultrathin-strut and thicker-
strut drug-eluting stents (DES) in patients with chronic (CCS) versus acute (ACS) coronary …

Coronary artery stenting is the treatment of choice for patients requiring coronary
angioplasty. We describe the major advancements with this technology. There have been …

Background Because of the advancement of bioabsorbable polymers and thinner struts,
bioabsorbable‐polymer sirolimus‐eluting stents (BP‐SES) with ultrathin struts may be …

Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary
Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial - PMC Back to Top …

Advances in stent design and the development of bioresorbable polymers have allowed the
development of novel stent technologies such as the Orsiro bioresorbable-polymer sirolimus …

Objectives The aim of this study was to determine 1-year safety and efficacy after treatment
with the COMBO and Orsiro stents. Background The COMBO stainless-steel stent has an …

Abstract Purpose of Review Stent design continues to evolve with newer generation of
stents aimed at improving clinical outcomes. This review compares different generations of …

Background Despite numerous studies supporting the outperformance of ultrathin-strut
bioresorbable polymer sirolimus-eluting stent (Orsiro SES, Biotronik AG), the generalizability …

Patients with diabetes mellitus are prone to increased adverse outcomes after percutaneous
coronary intervention, even with contemporary drug-eluting stents. Randomized controlled …